Home  >  TopNews
Msc_Apr23 Advertisement
you can get e-magazine links on WhatsApp. Click here
Export & Import + Font Resize -
PR_INDIA_Reg_Now_May_2023

IDMA seeks response from Saudi Arabia on supply of 300 life-saving drugs covering key therapeutic segments

Shardul Nautiyal, Mumbai
Monday, January 2, 2023, 08:00 Hrs  [IST]

The Indian Drug Manufacturers’ Association (IDMA) has sought urgent responses from Saudi Food and Drugs Authority (SFDA), Kingdom of Saudi Arabia on supply of 300 life-saving drugs in key therapeutic segments like AIDS, TB and BP among others based on the latter’s local medicinal requirement.

Saudi Arabia had a market size of $7.8 billion in 2021 for pharmaceuticals which included patented drugs of about $4.13 billion, generics at $2.87 billion and over-the-counter (OTC) drugs of $780 million, according to Pharmexcil.

Saudi Food and Drugs Authority (SFDA), Kingdom of Saudi Arabia had written a letter to the IDMA asking for the supply of medicines and shared the list of the drugs specified in it which stated, “SFDA, Kingdom of Saudi Arabia is inviting Indian Drugs and Pharmaceuticals manufacturers to participate in achieving drug security in the Kingdom of Saudi Arabia.”

“Due to technical or regulatory issues, availability of inputs in manufacturing faces problems in the Kingdom of Saudi Arabia. Executive Directorate for Regulatory Affairs in Drugs department of SFDA will be happy to resolve these issues in consultation with the respective company,” the letter read.

Following this, the IDMA had requested interested members to cater to the needs of Saudi Arabia and also specify the support required by their company.

Indian pharmaceutical companies were asked to supply drugs to Saudi Arabia in therapeutic segments covering therapeutic segments like AIDS, TB, hypertension, infectious diseases, bacterial infections and mental illness among others.

“We have sought certain queries like the quantity to be specified under each therapeutic segments and the market available to meet the demand on an urgent basis,” said IDMA secretary general Daara Patel.

The list of drugs include dexamethasone which is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, amlodipine, which is used to treat high blood pressure, ampicillin and sulbactam combination used to treat bacterial infections, atazanavir, an antiretroviral medication used to treat HIV/AIDS, atenolol used to treat high blood pressure and heart-associated chest pain, lamivudine which is used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2.

The list includes amitriptyline used to treat symptoms of depression and H1N1 influenza vaccine inactivated, lipase-protease-amylase digestive enzymes to help break down and digest fats, starch, and proteins in food.

 
Eppen_epMotion_May23

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
PharmaLytica
CPhI_China_2023
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |